Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Impact Of Covid-19 On Precision Medicine Market
3.2. Key Investment Insights
3.3. Porter’S Five Forces Analysis
3.3.1. Threat Of New Entry
3.3.2. Threat Of Substitution
3.3.3. Buyer’S Power
3.3.4. Supplier’S Power
3.3.5. Competitive Rivalry
3.4. Opportunity Matrix
3.5. Vendor Landscape
3.6. Technologies Related To Precision Medicine
3.7. Supply Chain Analysis
3.8. Regulatory Framework

4. Market By Application
4.1. Oncology
4.2. Infectious Diseases
4.3. Neurology/Physiatry
4.4. Cardiovascular
4.5. Lifestyle And Endocrinology
4.6. Gastroenterology
4.7. Other Applications

5. Market By Component
5.1. Applied Science
5.1.1. Genomics
5.1.1.1. Pcr
5.1.1.2. Pm Ngs
5.1.1.3. Genome Editing
5.1.1.4. Other Genomics Technologies
5.1.2. Pharmacogenomics
5.1.3. Other Applied Sciences
5.2. Precision Therapeutics
5.2.1. Clinical Trials
5.2.2. Cell Therapy
5.2.3. Drug Discovery And Research
5.2.4. Gene Therapy
5.3. Precision Diagnostics
5.3.1. Molecular Diagnostics
5.3.1.1. Non-Invasive Prenatal Testing (Nipt)
5.3.1.2. Companion Diagnostics
5.3.1.3. Liquid Biopsy
5.3.1.4. Other Molecular Diagnostics
5.3.2. Medical Imaging
5.3.2.1. Imaging Analytics
5.3.2.2. Imaging Computer-Aided Detection (Cadx)
5.4. Digital Health And Information Technology
5.4.1. Clinical Decision Support Systems (Cdss)
5.4.2. Big Data Analytics
5.4.3. It Infrastructure
5.4.4. Genomics Informatics
5.4.5. In-Silico Informatics
5.4.6. Mobile Health

6. Competitive Landscape
6.1. Key Strategic Developments
6.1.1. Mergers & Acquisitions
6.1.2. Product Launches & Developments
6.1.3. Partnerships, Contracts/Agreements & Collaborations
6.1.4. Business Expansions/ Approvals/ Announcements
6.2. Company Profiles
6.2.1. Abbott Laboratories
6.2.2. Bio-Rad Laboratories Inc
6.2.3. Eli Lilly & Company
6.2.4. F. Hoffmann-La Roche
6.2.5. Novartis Ag
6.2.6. Pfizer Inc



List of Figures


List of Figures


Figure 1: Chronic Conditions In Patients Hospitalized With Covid-19 In The United States
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: United States Precision Medicine Market, By Application, In 2020
Figure 7: United States Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 8: United States Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 9: United States Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 10: United States Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 11: United States Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 12: United States Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 13: United States Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 14: United States Precision Medicine Market, By Component, In 2020
Figure 15: United States Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 16: United States Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 17: United States Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 18: United States Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 19: United States Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 20: United States Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 21: United States Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 22: Biomarker’S Role In Pharmacogenomics
Figure 23: United States Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 24: United States Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 25: United States Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 26: United States Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 27: United States Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 28: United States Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 29: United States Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 30: United States Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 31: United States Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 32: United States Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 33: United States Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 34: United States Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 35: United States Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 36: United States Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 37: United States Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 38: United States Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 39: United States Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 40: United States Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 41: United States Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 42: United States Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 43: United States Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 44: United States Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE
TABLE 2: UNITED STATES PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: UNITED STATES PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: UNITED STATES PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: UNITED STATES PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: UNITED STATES APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: UNITED STATES APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: UNITED STATES GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: UNITED STATES GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: UNITED STATES PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: UNITED STATES PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: UNITED STATES MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: UNITED STATES MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES